CONTACT-01: A phase III, randomized study of atezolizumab plus cabozantinib versus docetaxel in patients with metastatic non-small cell lung cancer (mNSCLC) previously treated with PD-L1/PD-1 inhibitors and platinum-containing chemotherapy. Neal, J. W., Kundu, P., Tanaka, T., Enquist, I., Patel, S., Balestrini, A., Wang, J., Newsom-Davis, T., Goto, Y., Pavlakis, N., Kim, S. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.TPS9134

View details for Web of Science ID 000708120307045